Market Overview:
The global blood plasma products market is expected to grow at a CAGR of 5.8% from 2018 to 2030. The growth in the market can be attributed to the increasing incidence of chronic diseases, rising demand for plasma-derived therapies, and technological advancements in the field of blood plasma products. The immunoglobulins segment is expected to account for the largest share of the global blood plasma products market in 2018. This segment is driven by factors such as increasing prevalence of autoimmune diseases and rising demand for prophylactic immunoglobulin therapy. The coagulation factor concentrates segment is projected to grow at a higher CAGR during the forecast period owing to its growing use in hemophilia treatment. In terms of application, hospitals and clinics are expected to account for the largest share of the global blood plasma products market in 2018.
Product Definition:
Blood plasma products are used to replace or supplement the body's natural blood-clotting factors. They are also used to treat bleeding disorders and other medical conditions.
Immunoglobulins:
Immunoglobulins, also called as antibodies, are the proteins produced by the body's immune system in response to a foreign invader. The immune system uses immunoglobulins to identify and attack cells or substances that are harmful. Immunoglobulin is used in various medical treatments such as for allergies and autoimmune diseases like lupus & rheumatoid arthritis.
Coagulation Factor Concentrates:
Coagulation factor concentrates are a group of proteins that are found in the blood plasma. They help in preventing bleeding and clotting. Coagulation factor concentrates have different forms such as Fibrinogen, D-glucose, prothrombin complex concentrate (PCC), desmopressin, and epinephrine.
Application Insights:
The market is segmented by application into hospitals and clinics, research laboratories, and academic institutions. Hospitals and clinics dominated the overall application segment with a revenue share of over 60% in 2017 owing to increasing prevalence of chronic diseases such as diabetes, anemia, cancer which calls for frequent blood transfusions.
Research laboratories are expected to witness lucrative growth over the forecast period due to rising R&D activities pertaining to new product development for various applications such as therapeutics & vaccines or cell cultivation. Moreover, growing government funding towards stem cell research is anticipated to boost demand for fresh frozen plasma (FFP) and plateletpheresis products in the coming years.
Regional Analysis:
North America dominated the global blood plasma products market in 2017. The presence of well-established healthcare infrastructure, high awareness levels regarding blood donation and a large number of voluntary organizations that encourage people to donate blood are some factors attributing to its largest share.
Asia Pacific is expected to witness the fastest growth over the forecast period owing to an increase in patient population due to diabetes, cancer and other chronic diseases coupled with a rise in surgeries as well as medical procedures requiring various types of plasma derivatives such as packed red cells (PRC) and fresh frozen plasma (FFP). In addition, increasing government initiatives for promoting voluntary donations are also expected favorably impact market growth during the forecast period. ‘’Blood Donor Day’ was observed on 14th June 2018 by Ministry Of Health And Family Welfare, Government Of India ‘In memory of Dr.
Growth Factors:
- Increasing incidence of chronic diseases: The global prevalence of chronic diseases is increasing at an alarming rate. This is primarily because of the changing lifestyles and dietary habits of people across the world. According to a study by the World Health Organization (WHO), non-communicable diseases (NCDs) such as heart disease, stroke, cancer, and diabetes accounted for 63% of all deaths in 2012. Out of these, cardiovascular diseases alone caused 31% of all deaths worldwide. This high incidence of NCDs is expected to drive the demand for blood plasma products in the coming years.
- Growing awareness about blood donation: Blood donation plays a crucial role in saving lives by providing timely treatment to patients suffering from life-threatening conditions such as cancer or leukemia. In addition, it also helps reduce shortages faced by hospitals during emergencies or natural disasters when there is an increased demand for blood products.. As a result, there has been a growing awareness about blood donation among people around the world in recent years.. This has led to an increase in donations and drives initiatives organized by various organizations globally.. All these factors are expected to fuel growth prospects for the global Blood Plasma Products market over the forecast period
Scope Of The Report
Report Attributes
Report Details
Report Title
Blood Plasma Products Market Research Report
By Type
Immunoglobulins, Coagulation Factor Concentrates, Other
By Application
Hospitals And Clinics, Research Laboratories, Academic Institutions
By Companies
CSL Ltd., Creat Group Corporation, Grifols SA, Takeda, Octapharma AG, Kedrion SpA, Biotest AG, China Biologic Products, Sanquin, LFB S.A.
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
190
Number of Tables & Figures
133
Customization Available
Yes, the report can be customized as per your need.
Global Blood Plasma Products Market Report Segments:
The global Blood Plasma Products market is segmented on the basis of:
Types
Immunoglobulins, Coagulation Factor Concentrates, Other
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals And Clinics, Research Laboratories, Academic Institutions
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- CSL Ltd.
- Creat Group Corporation
- Grifols SA
- Takeda
- Octapharma AG
- Kedrion SpA
- Biotest AG
- China Biologic Products
- Sanquin
- LFB S.A.
Highlights of The Blood Plasma Products Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Immunoglobulins
- Coagulation Factor Concentrates
- Other
- By Application:
- Hospitals And Clinics
- Research Laboratories
- Academic Institutions
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Blood Plasma Products Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Blood plasma products are a type of blood product that is made from the plasma (the liquid portion) of whole blood. Plasma products are used to treat a variety of medical conditions, including bleeding disorders, cancer, and immune system deficiencies.
Some of the key players operating in the blood plasma products market are CSL Ltd., Creat Group Corporation, Grifols SA, Takeda, Octapharma AG, Kedrion SpA, Biotest AG, China Biologic Products, Sanquin, LFB S.A..
The blood plasma products market is expected to grow at a compound annual growth rate of 5.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Blood Plasma Products Market Overview 4.1 Introduction 4.1.1 Market Taxonomy 4.1.2 Market Definition 4.1.3 Macro-Economic Factors Impacting the Market Growth 4.2 Blood Plasma Products Market Dynamics 4.2.1 Market Drivers 4.2.2 Market Restraints 4.2.3 Market Opportunity 4.3 Blood Plasma Products Market - Supply Chain Analysis 4.3.1 List of Key Suppliers 4.3.2 List of Key Distributors 4.3.3 List of Key Consumers 4.4 Key Forces Shaping the Blood Plasma Products Market 4.4.1 Bargaining Power of Suppliers 4.4.2 Bargaining Power of Buyers 4.4.3 Threat of Substitution 4.4.4 Threat of New Entrants 4.4.5 Competitive Rivalry 4.5 Global Blood Plasma Products Market Size & Forecast, 2020-2028 4.5.1 Blood Plasma Products Market Size and Y-o-Y Growth 4.5.2 Blood Plasma Products Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Immunoglobulins
5.2.2 Coagulation Factor Concentrates
5.2.3 Other
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospitals And Clinics
6.2.2 Research Laboratories
6.2.3 Academic Institutions
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Blood Plasma Products Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Blood Plasma Products Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Immunoglobulins
9.6.2 Coagulation Factor Concentrates
9.6.3 Other
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospitals And Clinics
9.10.2 Research Laboratories
9.10.3 Academic Institutions
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Immunoglobulins
10.6.2 Coagulation Factor Concentrates
10.6.3 Other
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospitals And Clinics
10.10.2 Research Laboratories
10.10.3 Academic Institutions
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Immunoglobulins
11.6.2 Coagulation Factor Concentrates
11.6.3 Other
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospitals And Clinics
11.10.2 Research Laboratories
11.10.3 Academic Institutions
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Immunoglobulins
12.6.2 Coagulation Factor Concentrates
12.6.3 Other
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospitals And Clinics
12.10.2 Research Laboratories
12.10.3 Academic Institutions
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Immunoglobulins
13.6.2 Coagulation Factor Concentrates
13.6.3 Other
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospitals And Clinics
13.10.2 Research Laboratories
13.10.3 Academic Institutions
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Blood Plasma Products Market: Competitive Dashboard
14.2 Global Blood Plasma Products Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 CSL Ltd.
14.3.2 Creat Group Corporation
14.3.3 Grifols SA
14.3.4 Takeda
14.3.5 Octapharma AG
14.3.6 Kedrion SpA
14.3.7 Biotest AG
14.3.8 China Biologic Products
14.3.9 Sanquin
14.3.10 LFB S.A.